--- canonical_url: https://www.stockexpertai.com/earnings/met last_updated: 2026-05-05T21:44:14.676Z --- # MetLife, Inc. (MET) Q4 FY2026 Earnings Preview > **[stale-preview-note]** Note: this preview was published before the 2026-05-06 earnings report. Results have since been released — verify against the latest filings. > This content was automatically generated with FMP live data + Q4 FY2025 earnings call transcript. Generated: 2026-05-05T21:44:14.332Z. Educational tool, not investment advice. --- ## Quick Summary | Field | Value | Source | |---|---|---| | Price | $79.90 (▲ 1.20%) | fmp:quote | | Market Cap | $52.1B | fmp:profile | | 52w range | $67.33 – $83.85 | fmp:quote | | Earnings | Wed 6 May | fmp:earnings-history | | EPS estimate | $2.25 (+15% YoY) | fmp:earnings-estimate | | Revenue estimate | $19.5B | fmp:earnings-estimate | | Beat streak | 2/4 | fmp:earnings-history | | Rating | B+ (overall 3/5) | fmp:ratings | | Analyst median target | $97 (+20.8% upside) | fmp:price-target-consensus | | MoonshotScore | 47/100 | derived | | Council | 3/6 bullish | derived | | Munger verdict | Fairly Valued | derived | ## MetLife, Inc. — Q4 FY2026 Expectations Q4 consensus: revenue $19.5B^{[FMP est]}, EPS $2.25^{[FMP est]}. 2 consecutive quarters of beat^{[FMP earnings]}. ## Quick Take **Score:** B+ · **Stance:** BUY · **Council:** 3/6 · **Moonshot:** 47 = MoonshotScore 47^{[9-pillar formula]} + Council 3/6^{[6-lens rule]}. Form 4: 0 transactions^{[FMP Form 4]}. ## Watchlist (6 metrics) ### 1. Mim Aum Growth At year-end, MIM had $742 billion of assets under management, up from roughly $600 billion a year ago. > "To accelerate growth in asset management, we closed on the acquisition of PineBridge Investments and established a new business segment, MetLife Investment Management. At year-end, MIM had $742 billion of assets under management, up from roughly $600 billion a year ago." > — Michel Khalaf, President and Chief Executive Officer, Investor Focus · Q4 FY2025 ### 2. Group Benefits Growth MetLife's best-in-class group benefits business added approximately $100 million of new adjusted premiums, fees, and other revenues in 2025. > "Reinforcing our market leadership, our best-in-class group benefits business added approximately $100 million of new adjusted premiums, fees, and other revenues in 2025, with higher margin voluntary PFOs rising 10% year over year." > — Michel Khalaf, President and Chief Executive Officer, Investor Focus · Q4 FY2025 ### 3. Asia Sales Growth In 2025, Asia saw constant currency sales jump 18%, aided by a strong contribution from Japan, while Latin America saw constant currency sales rise by 12%, with Mexico leading the charge. > "In 2025, Asia saw constant currency sales jump 18%, aided by a strong contribution from Japan, while Latin America saw constant currency sales rise by 12%, with Mexico leading the charge." > — Michel Khalaf, President and Chief Executive Officer, Investor Focus · Q4 FY2025 ### 4. Free Cash Flow Generation In 2025, we made a $4.9 billion down payment toward that cumulative target. > "And where it all comes together, free cash flow—we committed to generate $25 billion over the course of five years. In 2025, we made a $4.9 billion down payment toward that cumulative target." > — Michel Khalaf, President and Chief Executive Officer, Investor Focus · Q4 FY2025 ### 5. Pension Risk Transfer MetLife originated more than $14 billion of pension risk transfer sales in 2025, MetLife's highest ever annual PRT total. > "We capitalize on our unique retirement platform by seeding a sidecar, Chariot Re, tapping the US retail retirement space via flow reinsurance, and originating more than $14 billion of pension risk transfer sales, MetLife's highest ever annual PRT total." > — Michel Khalaf, President and Chief Executive Officer, Risk Indicator · Q4 FY2025 ### 6. Expense Ratio Improvement In 2025 alone, aided by AI and other emerging technologies, we lowered our direct expense ratio to 11.7%, putting us well ahead of schedule. > "In 2025 alone, aided by AI and other emerging technologies, we lowered our direct expense ratio to 11.7%, putting us well ahead of schedule." > — Michel Khalaf, President and Chief Executive Officer, Investor Focus · Q4 FY2025 ## MoonshotScore Pillars | Pillar | Score | Level | Evidence | |---|---|---|---| | Revenue Growth | 10.0 | strong | Q4 vs Q1: fast growth (+30.4%) | | Gross Margin | 3.0 | weak | Q4: average margin (30.5%) | | Operating Leverage | 0.0 | weak | op margin weak (4.7%, under pressure) | | Cash Runway | 3.0 | weak | FCF very strong ($8.1B, 8089000000.0× CapEx) | | R&D Intensity | 3.0 | weak | low R&D investment (0.0%, weak innovation) | | Price Momentum | 7.0 | strong | RSI 66.3 positive momentum, 50d above | | News Sentiment | 7.0 | strong | majority buy (67%) | **Formula:** sum(pillar.score) / (count * 10) * 100. Each pillar deterministic from FMP. Source maps in pillar.formula. ## Council (7-Lens) | Name | Stance | Context | |---|---|---| | Ray Dalio | bull | macro · target upside +20.8% | | Ken Griffin | bull | flow · 50d MA above | | Jim Simons | neutral | quant · RSI 66 | | Klarman | neutral | value · target upside +20.8% | | Buffett | bull | quality · ROE score 4/5 | | Munger | neutral | valuation · target upside +20.8% | **Formula:** Each lens uses deterministic rule on bundle data. Logged in member.contextTr. ## Munger Lens - **Verdict:** Fairly Valued - **Financial Health:** Moderate - **Margin of Safety:** Moderate - **Interest Coverage:** Adequate - **ROIC vs WACC:** Healthy **Formula:** verdict=upside>25?Undervalued:>0?Fairly Valued:Overvalued. Each lens deterministic from FMP ratings + priceTarget. ## Technical Levels - **RSI(14):** 66.3 — yükselişte nötr — overbought sınırının altında, momentum pozitif - **50d MA:** $73 — hisse %8.8 üstünde — kısa vadeli destek - **200d MA:** $77 — hisse %3.2 üstünde — uzun vadeli destek - **Volume (10d):** -10% ## Past Performance (4 Quarters) | Quarter | EPS Actual | EPS Estimate | Result | Reaction | |---|---|---|---|---| | Q1 FY25 | $1.96 | $2.00 | MISS | +0.5% | | Q2 FY25 | $2.02 | $2.15 | MISS | -2.8% | | Q3 FY25 | $2.34 | $2.31 | BEAT | -3.4% | | Q4 FY25 | $2.58 | $2.34 | +10.3% EPS | -3.4% | Q4 (February 5, 2026): EPS $2.58 vs $2.34 est^[FMP], +10.3% beat. D+1 movement: -3.4%^{[FMP D+1]}. Decline despite beat — market reacted to guidance, not numbers. ## 3 Scenarios ### Scenario A · Beat **Q4 EPS > $2.25 + CapEx discipline** Threshold: EPS > $2.25^{[FMP est]}. Target: Break above median target $97^{[FMP target]}; high target $102^[FMP] upper bound. ### Scenario B · In-Line **EPS ≈ $2.25 + CapEx < $0** Threshold: EPS ≈ $2.25^{[FMP est]}, Q4 CapEx < $0^[FMP]. Target: Consolidation in the band between current $80^[FMP] and median $97^[FMP]. ### Scenario C · Miss **EPS < $2.18 or CapEx ≥ $0** Threshold: EPS < $2.18^{[FMP est×0.97]}. Target: Current $80 below SMA200 $77^[FMP], if rejection continues, $66^[derived] support activates. ## Risk Notes ### Primary segment below threshold Q4: EPS $2.58 vs $2.34 beat^[FMP], stock -3.4% D+1^[FMP]. ### Backlog concentration No RPO/backlog concentration disclosed in Q4 earnings call. ### Insider trading Form 4 data is marked in the table — this page does not generate assumptions for this stock. | Executive | Action | Amount | Date | |---|---|---|---| **Net:** — (0 transactions · 0 sells · 0 buys) · Q4 FY25 ### CapEx shock Q4 CapEx $0^{[FMP cashflow]}. Q4 op margin 4.7%^{[FMP op margin]} — this level in Q4 is sensitive to CapEx revision risk. ## Wall Street Consensus - **Median target:** $97 (+20.8% upside vs current $80) - **High / Low:** $102 / $90 - **Buy / Hold / Sell:** 12 / 6 / 0 - **Analyst count:** 5 (last quarter), 47 all-time ## Additional Transcript Insights ### 1. group_benefits_growth **Claim:** MetLife's best-in-class group benefits business added approximately $100 million of new adjusted premiums, fees, and other revenues in 2025. **Evidence (transcript):** "Reinforcing our market leadership, our best-in-class group benefits business added approximately $100 million of new adjusted premiums, fees, and other revenues in 2025, with higher margin voluntary PFOs rising 10% year over year." **Numbers:** $100 million, 10% ### 2. pension_risk_transfer **Claim:** MetLife originated more than $14 billion of pension risk transfer sales in 2025, MetLife's highest ever annual PRT total. **Evidence (transcript):** "We capitalize on our unique retirement platform by seeding a sidecar, Chariot Re, tapping the US retail retirement space via flow reinsurance, and originating more than $14 billion of pension risk transfer sales, MetLife's highest ever annual PRT total." **Numbers:** $14 billion ### 3. mim_aum_growth **Claim:** At year-end, MIM had $742 billion of assets under management, up from roughly $600 billion a year ago. **Evidence (transcript):** "To accelerate growth in asset management, we closed on the acquisition of PineBridge Investments and established a new business segment, MetLife Investment Management. At year-end, MIM had $742 billion of assets under management, up from roughly $600 billion a year ago." **Numbers:** $742 billion, $600 billion ### 4. asia_sales_growth **Claim:** In 2025, Asia saw constant currency sales jump 18%, aided by a strong contribution from Japan, while Latin America saw constant currency sales rise by 12%, with Mexico leading the charge. **Evidence (transcript):** "In 2025, Asia saw constant currency sales jump 18%, aided by a strong contribution from Japan, while Latin America saw constant currency sales rise by 12%, with Mexico leading the charge." **Numbers:** 18%, 12% ### 5. expense_ratio_improvement **Claim:** In 2025 alone, aided by AI and other emerging technologies, we lowered our direct expense ratio to 11.7%, putting us well ahead of schedule. **Evidence (transcript):** "In 2025 alone, aided by AI and other emerging technologies, we lowered our direct expense ratio to 11.7%, putting us well ahead of schedule." **Numbers:** 11.7% ### 6. free_cash_flow_generation **Claim:** In 2025, we made a $4.9 billion down payment toward that cumulative target. **Evidence (transcript):** "And where it all comes together, free cash flow—we committed to generate $25 billion over the course of five years. In 2025, we made a $4.9 billion down payment toward that cumulative target." **Numbers:** $25 billion, $4.9 billion --- *Data source: FMP (live query, 2026-05-05), Q4 FY2025 earnings call transcript (Translated to EN with Gemini 2.0 Flash). Educational tool, not investment advice.*